Speakers 2023

Aaron Tan

Medical Oncologist | Singapore

Aaron is a Medical Oncologist at the National Cancer Centre Singapore (NCCS), having completed his specialty training in Medical Oncology in Sydney, Australia. He also completed a PhD in cancer drug discovery at The University of Sydney. At NCCS, he completed a fellowship in drug development/early phase trials and lung cancer translational research. This includes an International Association for the Study of Lung Cancer (IASLC) Fellowship, which provided funding for a study of liquid biopsies to investigate MRD and early detection of recurrence in resected early stage lung cancers.

Aneez DB Ahmed

Director and Senior Consultant | Singapore

Dr Aneez D.B Ahmed is currently the Director & Senior Consultant Surgeon at International Centre for Thoracic Surgery in Mount Elizabeth Novena Specialist Centre, Singapore. He has been a practitioner in the field of thoracic surgery, with a special interest in thoracic oncology, for more than fifteen years. After completion of his cardiothoracic training from National University Hospital, Singapore, he passed his Fellowship exams from the Royal College of Surgeons of Edinburgh. Prior to starting his private practice, Dr Aneez served as the Head of Service of Thoracic Surgery in the Department of General Surgery in Tan Tock Seng Hospital (TTSH), Singapore. His interest in robotic surgery led him to be recognised as the first in the ASEAN cohort to get a Level III Certificate Specialist training in Robotic Thoracic Surgery from the European College of Cardiothoracic Surgery (EACTS). With sabbaticals in Europe and USA for advanced training in Robotic Thoracic surgery, he now leads the training program for thoracic surgeons in ASEAN and South Asia. He then became the Vice President of Robotic Surgical Society of Singapore (RS3) in 2016 and subsequently being nominated as the President of RS3 in 2019. His special interest in chest wall surgery led him to be a pioneer in Chest Wall Resection and Reconstruction. Dr Aneez had also performed the world’s first 3D Printed Polymer Ribcage Reconstruction. Dr Aneez is a member of various thoracic surgical groups internationally. He is also the Thoracic domain board member at the Asian Society of Cardiothoracic Surgery (ASCVTS), and he is the current General Secretary of the South East Asian Society of Thoracic Surgery (SEATS). His expertise and knowledge in minimally invasive thoracic surgery have led to numerous invitations as a speaker to conferences and workshops in the region. He also receives referrals from other hospitals in the country and other regions such as Malaysia, Thailand, Philippines and the U.A.E. Besides clinical works, Dr Aneez is passionate about teaching. Since 2010, Dr Aneez piloted a program in Advanced Thoracic Nursing Course (ATNC) at TTSH that has been running annually to train nurses from all over Asia. He is also an examiner for the Royal College of Surgeons of Edinburgh.

CHEE Cheng Ean

Senior Consultant | Singapore

Dr Chee is a senior consultant medical oncologist and clinician investigator at the National University Cancer Institute, Singapore (NCIS). She also holds the Deputy Director (Clinical) position at NCIS and is Assistant Professor at Yong Loo Lin School of Medicine, NUS, Singapore. She is board certified by the American Board of Internal Medicine (ABIM) in Internal Medicine, Medical Oncology and Hematology. Dr Chee’s specializes in GI Oncology. Her interests are in drug development of novel agents, clinical trials, cancer survivorship and care delivery.

Chia Puey Ling

Medical Oncologist | Singapore

Dr Chia Puey Ling is a Medical Oncology Consultant at Tan Tock Seng Hospital with subspecialty interest in thoracic and genitourinary oncology. After completing her basic physician training in Singapore, she underwent advanced specialist training in Medical Oncology in Melbourne, Australia. She received the International Association for the Study of Lung Cancer (IASLC) Fellowship Award and the University of Melbourne Postgraduate Award and completed a PhD research on the study of tumour microenvironment and biomarkers in malignant mesothelioma for oncogenic targeted therapies. She is the principal investigator or co-investigator for several international multi-centre cancer clinical trials and published numerous first-author papers in her speciality of interest.

Chikako Shimizu

Director, Comprehensive Cancer Center Head, Department of Breast and Medical Oncology | Japan

Dr. Chikako Shimizu, MD. PhD, is a medical oncologist graduated from Medical School of Tokyo Medical and Dental University in 1996. She worked at Department of Breast and Medical Oncology in National Cancer Center Hospital between 2003-2018 and earned her master’s degree by a translational study related to trastuzumab in 2015. She currently serves as Head of Department of Breast and Medical Oncology and Director of Comprehensive Cancer Center at National Center for Global Health and Medicine. She has had special interest in breast cancer in young women, which led her to develop the first onco-fertility guideline in Japan.

Choo Su Pin

Medical Oncologist | Singapore

Dr Choo Su Pin is a medical oncologist who specializes in gastrointestinal cancers including colorectal, upper gastrointestinal, pancreas, hepatobiliary, peritoneal, and anal cancers. She is also a visiting consultant at the National Cancer Centre, Singapore and Adjunct Associate Professor, Singhealth Duke-NUS Oncology Academic Clinic Programme, Duke-NUS Graduate Medical School Singapore.

Daniel Tan

Senior Consultant Medical Oncologist | Singapore

Daniel Shao-Weng Tan, B.Sc. (Hons), MBBS (London), MRCP (UK), PhD, is a Senior Consultant Medical Oncologist at Division of Medical Oncology at National Cancer Centre Singapore, an Associate Professor (Tenure-Track) at Duke-NUS Medical School, and a Senior Clinician-Scientist at Genome Institute of Singapore. Dr. Tan has a specialist interest in thoracic, head and neck oncology and cancer drug development. Dr Tan’s work is focused on addressing the translational gap between basic science and clinical practice – particularly in improving our understanding of the determinants of response and resistance to targeted therapy and immunotherapy.

David Tan

Senior Consultant, Department of Haematology-Oncology | Singapore

Dr David Tan is a medical oncologist and clinician scientist at the National University Cancer Institute, Singapore. He is an Associate Professor at the Yong Loo Lin School of Medicine, NUS and Principal Investigator at the Cancer Science Institute, NUS. He is also Head of the Innovation Transfer Office at National University Health Systems (NUHS). His primary clinical and research interests are in gynaecological (ovarian, endometrial and cervical) cancers and the development of novel anti-cancer therapeutic agents. Dr Tan graduated from Guy’s, King’s and St Thomas’ School of Medicine, University of London, UK with a BSc in Experimental Pathology (1st Class Honours) and MBBS with Distinction. He undertook training in internal medicine at Hammersmith Hospital and Guy’s and St Thomas’ Hospitals in London before being awarded a Cancer Research UK Research Fellowship at The Institute of Cancer Research in London, where he obtained his PhD in Oncology. He subsequently completed his specialist training in medical oncology at The Royal Marsden Hospital in London. After working in the Drug Development Unit at The Royal Marsden Hospital/ Institute of Cancer Research, he completed another fellowship at the Princess Margaret Cancer Centre, University of Toronto, Canada, in Drug Development and Gynaecologic Oncology before returning back to Singapore.

Evelyn Wong

Medical Oncologist | Singapore

Dr. Evelyn Wong is a Medical Oncologist who practices at National Cancer Centre Singapore (NCCS) and Changi General Hospital. She specializes in Gastrointestinal Oncology, which includes upper gastrointestinal, hepatobiliary, and lower gastrointestinal cancers. She founded AYABytes, a mobile app, co-created by patients and physicians, for Adolescents and Young Adults (AYA) cancer patients, and is a founding member of the AYAO Service at NCCS. She was the Director of Seeds of Nations Pte Ltd (2013-2017), a corporation focused on global community projects. She currently holds a concurrent appointment as a faculty member under Oncology ACP, DUKE-NUS Global Health Institute. She is passionate about gastrointestinal oncology, patient empowerment, and improving health equity through modelling and medical innovation. She aspires to use real-world data and implementation research to improve the outcomes of oncology patients.

Faye Lim

senior radiation oncologist | Singapore

Dr Faye Lim is a senior radiation oncologist at the National Cancer Centre Singapore with a special interest in breast and upper and lower GI cancers. Her special interests include optimising radiotherapy and its sequencing with other treatment modalities in the treatment of cancers .

Felicia Chin

Gynaecological Oncologist | Singapore

Dr Felicia Chin Hui Xian is a Consultant with the Department of Gynaecological Oncology, KK Women's and Children's Hospital. Dr Chin has been an accredited specialist in Obstetrics and Gynaecology since 2016, and underwent subspecialty training in Gynaecological Oncology. She was awarded the Singhealth Health Manpower Development Plan Award in 2019 and completed her fellowship in Fertility Sparing Management in Gynaecological Cancers at the Royal Women’s Hospital, Melbourne. In 2020, Dr Chin spearheaded the Gynae Oncofertility Service in KKH, a first-in-Singapore service, which provides holistic care for young women with cancer.

Frances Victoria

Clinical Instructor | Philippines

Dr Frances Victoria Que completed her internal medicine residency and medical oncology fellowship training at St Luke’s Medical Center, Quezon City, Philippines, an observership in cancer genetics at the National University Hospital Singapore, and cancer genomic medicine fellowship training at the National Cancer Center Singapore. She is currently a clinical instructor at the St Luke’s College of Medicine, Philippines, and an active consultant for internal medicine, medical oncology, and cancer genetics and genomics at St Luke’s Medical Center Quezon City and Global City, Philippines.

Han Shuting

Medical Oncologist | Singapore

Dr. Han Shuting is a Consultant Medical Oncologist at the National Cancer Centre Singapore. he is currently pursuing a PhD at the National University of Singapore under the National Medical Research Council (NMRC) research training fellowship award. She sub-specialises in gastrointestinal cancers and her areas of research include colorectal cancers, viral-driven cancers and immuno-oncology

Iain Tan

Senior Consultant Medical Oncologist | Singapore

Dr. Iain Tan is a Senior Consultant Medical Oncologist, leading the colorectal cancer service in Division of Medical Oncology, National Cancer Centre Singapore. He is the director of research for the division of Medical Oncology and the director of the NCCS-Satellite Tissue Repository. He is a clinician scientist (twice NMRC CSA awardee) and assistant professor at Duke-NUS and faculty member and principal investigator of the laboratory of applied cancer genomics in the Precision Medicine And Population Genomics program at Genome Institute of Singapore, A-Star and adjunct faculty at Cancer & Stem Cell Biology Program at Duke-NUS. He has published widely with over 80 publications (h-index 36) including first or senior/corresponding author publications in Journal of Clinical Oncology, Nature Genetics, Nature Medicine, Nature, JAMA. He has obtained numerous individual competitive grants (CS-IRG, CSA, IAF-ICP), is the corresponding principal investigator of a national collaborative grant on cancer liquid biopsies (IAF-PP, Calibre, $15 million) and is the co-investigator, theme or platform PI of other national collaborative projects (LCGs & IAF-PPs). He mentors multiple junior clinician scientists (mentor for 2 NMRC transition awardees) post-docs, PhD students including clinician scientist PhD students. His research focuses on the immuno-biology of colorectal cancer and non-invasive diagnostics. He is a member of the resident advisory committee and the chairman of the exit examinations for Medical Oncology. For his research, he has received the ASCO Young Investigator Award (2010) and ASCO Merit Award (2011). For his research and clinical service, he received the National Youth Award (2014), the country’s highest award for youths.

Jack Chan

Consultant Medical Oncologist | Singapore

Dr Jack Chan is a Consultant Medical Oncologist at National Cancer Centre Singapore and KK Women’s and Children’s Hospital, subspecialising in gynaecological and breast cancers. Dr Chan serves as Secretary of Gynecologic Cancer Group Singapore. His research interests include early and late phase clinical trials and translational work in female cancers.

Jason Chan

Consultant Medical Oncologist | Singapore

Dr Jason Chan is Consultant Medical Oncologist at the National Cancer Centre Singapore and Assistant Professor at Duke-NUS Medical School. He has special clinical interests in lymphomas and rare cancers including sarcomas and melanomas. His key research interests lie in unravelling the causes and molecular pathobiology of rare cancers with the aim of improving clinical care of patients inflicted with these diseases.

Jens Samol

Senior Consultant | Singapore

Dr Samol is the Clinical Lead for Thoracic Cancers, Lymphoma (within Medical Oncology) and Sarcoma as well as the Clinical Lead for Genetic Counselling and Clinical Cancer Genetics & Genomics Service at TTSH. He is the Director for Clinical Trials (CRIO), Co-Director (TTSH) for P.H.Feng Research Centre and is the Clinical Research Lead of the Medical Oncology Department at TTSH. Dr Samol holds a faculty appointment as an Assistant Professor at Lee Kong Chian School of Medicine, Singapore, as well as an Assistant Professor of Oncology at Johns Hopkins University School of Medicine, Baltimore, USA. He treats patients with all types of solid cancers and lymphoid neoplasms. He has a particular interest in Thoracic Cancers, Gastrointestinal Cancers (including HIPEC), Head & Neck Cancers, Sarcoma, and Lymphoma.

Johan Chan

Associate Consultant | Singapore

Dr Johan Chan is a Consultant in the Division of Medical Oncology of the National Cancer Centre Singapore. He completed his medical oncology specialty training in Australia. As part of his specialist training, he completed a fellowship in National Cancer Centre Singapore and continued practising as an Associate Consultant. His research interest includes GU oncology and Geriatric oncology.

Joline Lim

Consultant and Clinician Scientist | Singapore

Dr Joline Lim is a consultant and clinician scientist at the National University Cancer Institute, Singapore. Her primary clinical and research interests are in breast oncology and early phase clinical trials, with a special focus on the development of novel anti-cancer therapeutic agents and biomarkers. Dr Lim has a keen interest in translational research involving novel anti-tumour therapies including molecular targeted agents and immunotherapies, and the application of emerging predictive and pharmacodynamic biomarkers.

Joycelyn Lee

Consultant | Singapore

Dr Joycelyn Lee graduated from National University of Singapore and completed her post-graduate training in Medical Oncology at National Cancer Centre Singapore. Her clinical and research interests are in gastrointestinal malignancies, particularly hepatopancreatobiliary cancers and immuno-oncology.

Kenneth Chen

Consultant, Urology | Singapore

Dr Kenneth Chen is a consultant Uro-oncologist with Singapore General Hospital. He holds a Masters in Clinical investigation and has special interests in Robotic and Minimally Invasive Surgery and Genitourinary Oncology, having completed a fellowship at Sir Peter MacCallum Cancer Centre in Australia. His academic interests include prostate cancer diagnostics and novel device development and he is currently working on a drug eluting stent for the treatment of ureteric diseases. He holds the teaching position of a clinical Associate Professor with Duke-NUS Graduate Medical School and is a clinical lecturer with the National University of Singapore YLL School of Medicine.

Kevin Chua

Radiation Oncologist | Singapore

Dr Kevin Chua is a practicing radiation oncologist in the National Cancer Centre, Singapore. His clinical interests include the use of novel radiotherapy techniques for the treatment of patients with thoracic and central nervous system malignancies. He has a keen interest in research and education and has presented his work in both local and international conferences. His research interests lie in the discovery of biomarker signatures for radio-resistance.

Krishnansu S. Tewari

Gynecological oncologist | USA

Krishnansu Tewari, M.D., is a gynecological oncologist and Associate Professor for the Division of Gynecologic Oncology at University of California, Irvine. Dr. Tewari is certified by the American Board of Obstetrics and Gynecology in Gynecological Oncology and serves as Vice President of the Orange County Obstetrics and Gynecology Society. He graduated from the UC Irvine School of Medicine where he also completed his fellowship and residency. Specializing in ovarian, endometrial, cervical and other gynecologic cancers, Dr. Tewari is highly trained in minimally invasive robotic-assisted surgery. He has received awards from the International Gynecologic Cancer Society, America’s Top Doctors, and Best Doctors in America for his treatment of gynecologic cancers. Dr. Tewari continues to dedicate his career to the early diagnosis and treatment of gynecologic cancers.

Kumar Prabhash

Medical Oncologist | India

Dr. Kumar is Professor, Medical Oncology at Tata Memorial Hospital and has more than two decades of experience. He has published over a hundred research and review articles/papers in journals of national and international repute.He has undertaken over 80 projects as Principal Ivestigator and Co-Investigator.He is a member of many international and national scientific societies and associations and has delivered talks in several conferences.

Lee Soo Chin

Senior Consultant | Singapore

She is the Head and Senior Consultant in Medical Oncology and Associate Director of Research at the National University Cancer Institute, Singapore, and Senior Principal Investigator at the Cancer Science Institute, Singapore. She is ex-Chairperson of the Chapter of Medical Oncologists, Academy of Medicine, Singapore, and has been a member of the Ministry of Health Specialist Accreditation Board for Medical Oncology since 2009. She has been Chair of the National Healthcare Group Domain-Specific Ethics Review Board B since 2008. She is also a member of the Singapore Ministry of Health Drug Advisory Committee for Oncology drugs. She specialises in breast cancer and directs the Cancer Genetics program at the National University Cancer Institute, Singapore. Her research focus is on breast cancer, pharmacogenetics and cancer genetics, and she has been the Principal Investigator of more than 40 industry-sponsored and investigator-initiated breast cancer clinical trials. She directs the Haematology-Oncology Research Group, a cancer clinical trials unit that conducts 100-120 phase I-III therapeutics clinical trials in solid tumours and haematological malignancies at the National University Cancer Institute.

Lee Suat Ying

Consultant | Singapore

Dr Lee Suat Ying graduated from NUS Yong Loo Lin School of Medicine in 2013, and went on to complete her Internal Medicine Junior Residency in Singhealth. She subsequently completed her Senior Residency in Medical Oncology in 2020 and has been practicing in the National Cancer Centre Singapore since as a member of the Gastrointestinal Oncology group.

Li Shao Tzu

Genetic Counselor | Singapore

Ms. Shao-Tzu Li currently work as a Genetic Counsellor at National Cancer Centre Singapore. She holds two Master Degrees: Master of Science in Clinical Laboratory and Medical Technology form Colleague of Medicine, National Taiwan University in 2008 and Master of Science in Generic Counselling from Icahn School of Medicine at Mount Sinai, New York, USA in 2015. She is a certified genetic counsellor by American Board of Genetic Counselling (ABGC) and started to practice as a genetic counsellor in National Cancer Centre Singapore since 2015. She was a recipient of Singapore Health Quality Service Awards 2017. Her clinical and research interests include Cancer Genetics, Inherited Bone Marrow Failure Syndrome and Hereditary Haematological Malignancies. She is a member of the SingHealth Allied Health Executive Committee and Genetic Counsellor Professional Committee.

Ma Jun

Medical Oncologist | Singapore

Dr Choo Su Pin is a medical oncologist who specializes in gastrointestinal cancers including colorectal, upper gastrointestinal, pancreas, hepatobiliary, peritoneal, and anal cancers. She is also a visiting consultant at the National Cancer Centre, Singapore and Adjunct Associate Professor, Singhealth Duke-NUS Oncology Academic Clinic Programme, Duke-NUS Graduate Medical School Singapore.

Manasadevi Karthikeyan

Genetic Counsellor | Singapore

Manasadevi Karthikeyan (Manasa) is a Genetic Counsellor at the National Cancer Centre Singapore. She completed her Bachelor’s in Genetic Engineering in India, when she formed an interest in patient care where she can adapt her genetics knowledge. She completed her Master’s degree in Genetic and Genomic Counselling from the University of Glasgow in the United Kingdom. As a Genetic Counsellor, she works closely with cancer geneticist, medical oncologists and research scientists to provide holistic care and support to her patients and their families. Her interests include genetic testing equity and spreading awareness about genetics and genetic counselling to the world.

Mitsuho Imai Sumida

Medical Oncologist | Japan

Mitsuho Imai-Sumida is one of the core members of SCRUM-Japan, a leading organization dedicated to conducting global clinical trials for the development of pharmaceuticals and medical devices in cancer treatment. With a nationwide reach, SCRUM-Japan handles various aspects of clinical trial planning, regulatory approval, and coordination across approximately 200 facilities. As an accomplished oncologist specializing in gastroenterology, she completed their clinical training at a prestigious oncology-focused general hospital in Tokyo. Building upon this foundation, they pursued further research during their doctoral program at the University of Tokyo, delving into the intricate domains of cancer microenvironment and autophagy. Subsequently, as a post-doctoral fellow at UCSF, she extended their expertise to encompass the study of lncRNA and epigenetics. Mitsuho Imai-Sumida actively contributes to the development of infrastructure for cancer genetic medicine as a member of a dedicated working group. Their involvement in this initiative aligns with their commitment to providing specialized outpatient care at one of the 12 hospitals recognized by the Japanese government as a core genome center. Through their multifaceted role, she is not only advances the ongoing development project but also ensures the delivery of exceptional medical services to patients. With their extensive experience in clinical oncology, comprehensive research background, and active participation in cutting-edge medical initiatives, she continues to make significant contributions in the field of cancer treatment and genetics

Nitesh Rohatgi

Senior Director Medical Oncology | India

Dr. Nitesh Rohatgi is Senior Director Medical Oncology at Fortis Memorial Research Institute, Gurugram, he was previously working at the prestigious London Oncology Clinic (Leaders in Oncology care), Harley Street, London. He is a fellow of the Royal College of Physicians (U.K Edinburgh) as well as Royal Society of medicine. Besides being a key opinion leader in Oncology in India he has been a PI on clinical trials (presently for BIRAC -Oncology) and has much publication to his name. He was trained in medical oncology, palliative medicine and teenage young adult’s cancers in United Kingdom, completing his CCT in 2009.

Raymond Ng

Assistant Professor | Singapore

Assistant Professor Ng graduated from Otago Medical School in New Zealand in 1994 and attained his specialist oncology fellowship from the Royal Australasian College of Physicians in 2004. Following this he spent a year as a Clinical Research Fellow at Royal Melbourne Hospital in Australia and subsequently an additional two years as a Clinical Fellow at Princess Margaret Hospital in Toronto, Canada. His work in Canada focused primarily on clinical care as well as a special interest on health outcomes research in breast and lung cancer. He returned to Singapore in 2007 at the National Cancer Centre Singapore and is now currently a Senior Consultant within the breast oncology team. In this intervening period he also completed a Master in Public Health in 2010. He is also passionate about medical education and spends part of his time every week lecturing and mentoring medical students at the University

Robert Walsh

Associate Consultant, Department of Haematology-Oncology | Singapore

Dr Robert Walsh is an Associate Consultant in Medical Oncology at the National Cancer Institute, Singapore. He obtained his undergraduate degree from the University of Cambridge and has worked in the Singapore health system since 2013, completing postgraduate residency training in Internal Medicine and Medical Oncology at the National University Health System, Singapore. Dr Walsh's areas of clinical focus include genitourinary and gastrointestinal malignancies with an ongoing research interest in precision oncology..

Ryan Tan

Consultant Medical Oncologist | Singapore

Dr. Ryan Tan is a Consultant in the Division of Medical Oncology at National Cancer Centre Singapore. He is actively involved in Informatics research within the National Cancer Centre of Singapore (NCCS). Dr Tan completed his specialist training in Medical Oncology at NCCS, and is a Fellow of the Academy of Medicine, Singapore. Dr Tan's sub-specialty interests are breast cancer and gynaecological cancer. His research interests include Informatics and Artificial Intelligence and their application in healthcare.

Samuel Ow

Senior Consultant | Singapore

Dr Samuel Ow is a Senior Consultant Medical Oncologist in the Department of Haematology-Oncology, National University Cancer Institute, Singapore (NCIS). He received the Dean's Award for Outstanding House Officer of his entire cohort, and obtained the Masters of Medicine (Internal Medicine) and Membership of the Royal College of Physicians (UK) on an MOHH Postgraduate Exam Scholarship. He subsequently successfully completed his specialty training in Internal Medicine and Medical Oncology at NCIS where he served as Chief Registrar, and was also selected for the inaugural Singapore Chief Residency Program. Dr Samuel Ow's clinical and research interests are in Breast Cancer and Clinical Cancer Genetics.

Sanjay Popat

Consultant Medical Oncologist | United Kingdom

Professor Popat has both a private and an NHS practice at The Royal Marsden. He is a Consultant Medical Oncologist at The Royal Marsden, Professor of Thoracic Oncology at the Institute of Cancer Research, and is an internationally recognized expert in the treatment of lung cancer, mesothelioma and cancers of the thymus (thymoma and thymic carcinoma). Professor Popat qualified in 1994 from Guy’s and St Thomas’ Hospitals with triple distinction and was awarded a PhD in Molecular Genetics in 2002, undertaking a postdoctoral Clinician Scientist Fellowship and a HEFCE Clinical Senior Lectureship thereafter. He has been awarded nationally and internationally competitive prizes for his research, in addition to four research fellowships. His research interests include the complexities of genetic profiling in cancer, as well as developing novel drug treatments through clinical trials. He also holds several national and international roles. Nationally, Professor Popat Chairs the British Thoracic Oncology Group (BTOG) Steering Committee, is Co-Director for the NIHR London South Clinical Research Network Cancer Division, the NIHR Lung Cancer National Specialty Lead and is past Sub-group Chair of the NCRI Lung Group. Internationally, he sits on the Foundation Council of the European Thoracic Oncology Platform (ETOP) and is active in the European Society of Medical Oncology (ESMO) where he has co-authored European Clinical Practice Guidelines for Small Cell Lung Cancer, Non-Small Cell Lung Cancer, and Mesothelioma. His research collaborations with industry have led to licensing of several drugs globally, leading to implementation in International treatment guidelines and NHS funding approvals. Professor Popat is often an invited Clinical Expert to the National Institute for Health and Care Excellence (NICE) and sits on several committees overseeing the safety and governance for ongoing UK and international clinical trials. Sanjay is a strong advocate for patient education and support and is clinical advisor to several patient-facing cancer charities.

Shaheenah Dawood

consultant medical oncologist | United Arab Emirates

Shaheenah Dawood is a consultant medical oncologist and professor in clinical oncology in the United Arab Emirates. She currently leads the oncology clinical trials program at Mediclinic City Hospital Dubai. She also serves as president of the Excellence in Oncology Care summit that is held annually in Dubai and is co-president of the Asia-Pacific Breast Cancer Summit (APBCS) and Asia-Pacific Gastroenterology Cancer Summit (APGCS). She has also recently launched the International BRCA Forum and Young Women’s Forum.

Shona Nag

Consultant Medical Oncologist | India

Dr. Shona Nag is one of Pune’s best breast cancer specialists and a leading medical oncologist. She is known for her work in women’s health especially that for breast cancer and cervical cancer. She has over 27 years of experience and has made it her mission to encourage everyone to understand cancer better, especially women. As the Director, Oncology at Sahyadri Group of Hospitals in Pune, Dr. Shona Nag has been instrumental in helping patients navigate cancer better. She was 10 when she decided that she wants to be a doctor. After completing her school, she studied medicine at Pune’s BJ Medical College. She followed that by an oncology fellowship at Tata Memorial Hospital in Mumbai. One of Pune’s best breast cancer specialists and leading medical oncologist,.Dr. Shona Nag believes that breast cancer is a social issue that deserves attention and quick treatment. She is cervical cancer and ovarian cancer specialist and is known as the Best Oncologist in India. Currently, she is the director of the Oncology Department at Sahyadri Group of Hospitals, Pune, Consultant Medical Oncologist at KEM Hospital, Mumbai. In the past, she was the Chairman of MOG (Maharashtra Oncology Group) and Project Director Oncology of Jehangir Clinical Research Development Centre (JCDC). In the present, she is looking at pushing for new facilities and better care for breast cancer patients. Be it via launching the First Breast Care Unit in Pune in 2016, or a fully equipped day-care for chemotherapy or even being the first hospital to receive the scalp cooling machine. Dr. Shona Nag has also converted the Nag Foundation set up by her mother-in-law Surabhi Nag into one focused on cancer treatment, prevention, and care. Dr. Shona Nag has also been rewarded for her research in cancer. She has received the ISCR award in 2010 for the best research site and the GSK-ERI award for ethnic research in breast cancer.

Sowmya Jonnagadla

Genetic Counsellor | Singapore

Sowmya Jonnagadla is a genetic counsellor from the National Cancer Centre Singapore. She is originally from India and was trained in Australia. While studying biology in high school, she developed an intense curiosity towards genetics and that fascination has never stopped! She is particularly interested in the psychosocial impact of hereditary cancer conditions to enable better support to individuals and their families. She aims to continue educating healthcare professionals and spreading awareness about genetic conditions among the public.

Tae Won Kim

Professor of Department of Oncology | Korea South

Tae Won Kim, MD, PhD is currently Professor of Department of Oncology at Asan Medical Center, and the president of Asan Cancer Institute at Asan Medical center, Korea. He worked as a chairperson of the Korea Society of Medical Oncology(KSMO). Dr. Kim earned his bachelor’s degree from the Seoul National University College of Medicine, Korea, and completed his master’s and doctoral degrees from the University of Ulsan College of Medicine, Korea. Currently, he has been focusing on clinical research and digital solution for cancer care. He has published journals about cancer and biomarkers in several journals including Nature, Lancet Oncology, Annals of Oncology.

Tan Wei Chong

Associate Consultant | Singapore

Dr Tan is an associate consultant with the National Cancer Centre Singapore. He obtained his basic medical degree from Monash University, Australia in 2013, completed his Residency in Internal Medicine in Singapore in 2018, and subsequently completed his senior residency in Medical Oncology in 2021 in National Cancer Centre Singapore.

Tanujaa Rajasekaran

Medical Oncologist | Singapore

Dr Tanujaa Rajasekaran is a Senior Consultant, Medical Oncologist at Parkway Cancer Centre. She is experienced in general medical oncology, with subspecialty interests in the management of lung, genitourinary, head and neck cancers and geriatric oncology. Prior to joining Parkway Cancer Centre, Dr Tanujaa served as a Consultant at National Cancer Centre Singapore and as the Medical Director of the Changi General Hospital oncology unit. Dr Tanujaa is actively involved in medical education. She was a core faculty member of the Medical Oncology Senior Residency Program, as well as a Clinical lecturer at Yong Loo Lin School of Medicine, NUS.

Toh Chee Keong

Medical Oncologist | Singapore

Dr Toh is a medical oncologist who sub-specializes in thoracic oncology including lung cancers and thymic cancers, genitourinary oncology including prostate, kidney, bladder and testicular cancers, as well as head and neck cancers. He was working at the National Cancer Centre Singapore for majority of his career, with a 3 year-stint intercalated at Raffles Cancer Centre where he was director of clinical research, before joining Curie Oncology. Throughout the years, he was involved in clinical work, clinical trials and teaching. Among his many achievements, he was one of the first who published on the clinical characteristics of lung cancer among the never-smokers.

Tony Mok

Chairman, Department of Clinical Oncology | Hong Kong S.A.R

Professor Tony S.K. Mok, BMSc, MD, FRCP(C), FRCP(Edin), FHKCP, FHKAM(Medicine), FASCO was trained at the University of Alberta, Canada and he subsequently completed a fellowship in medical oncology at the Princess Margaret Hospital in Toronto. After working as a community oncologist in Toronto, Canada for seven years, he returned to Hong Kong in 1996 to pursue an academic career. Professor Mok is the Li Shu Fan Medical Foundation endowed Professor and Chairman of Department of Clinical Oncology at the Chinese University of Hong Kong. His main research interest focuses on biomarker and molecular targeted therapy in lung cancer. He was the Principal Investigator and first author on the landmark IPASS, which was the first study that confirmed the application of precision medicine for advanced lung cancer. He has also led and co-led multiple international phase III studies including the FASTACT 2, PROFILE 1014, IMPRESS, ARCHER 1050, ALEX, AURA 3 and KEYNOTE 042. These projects address various aspects on management of advanced lung cancer, and basically have defined the current practice. He dedicates his work on precision medicine for lung cancer by also engaging in clinical research on oncogene driven lung cancer and immunotherapy. His work has been adopted by multiple international guidelines including NCCN, AMP/IASLC/CAP, ASCO and ESMO. He also contributes to the development of clinical research infra-structure in China and Asia. He cofounded the Lung Cancer Research Group, Chinese Thoracic Oncology Research Group and Asia Thoracic Oncology Research Group.

Vineet Talwar

Director, Department of Medical Oncology | India

Dr Vineet Talwar is presently working as Director, Department of Medical Oncology in Rajiv Gandhi Cancer Institute and Research Centre since the past 21 years. He completed his OM (Medical Oncology) training from Cancer Institute, Chennai in March 2000. He has over 50 publications in national and international journals and is a member of the European Society of Medical Oncology (ESMO), American Society of Clinical Oncology (ASCO), Indian Cooperative Oncology Network (ICON), Indian Society of Oncology (ISO). He has been awarded 3 orations from the Association Physician of India, Indian Academy of Clinical Medicine, Sir Ganga Ram Hospital. He was awarded the prestigious HJKI RA Award by the Delhi State Medical Associate for his efforts in the field of cancer. He is a fellow of Royal College of Physicians Edinburgh (FRCP) and also credited as a Fellow of International Medical Sciences Academy (FIMSA). He is actively involved with the DNB Medical Oncology Program which is being conducted at Rajiv Gandhi Cancer Institute and presently is a thesis guide for diplomate national board (DNB) students in Medical Oncology. He actively participates in oncology updates, cancer detection camps, outreach clinics and drug trials (Phase I, II, III) at the Institute. He has avid interests in breast, GI and GU cancers.

Zhang Zewen

Associate Consultant Medical Oncologist | Singapore

Dr Zhang Zewen is an Associate Consultant in the Department of Medical Oncology, National Cancer Centre Singapore (NCCS), and subspecialized in Breast and Gynecology Cancer. His primary research interest is in Cancer Genetics, and is part of the Cancer Genetics Service team over at NCCS . In addition, he believes in clinical education and mentorship, and holds the appointment of Clinical Instructor with the SingHealth Duke-NUS Oncology Academic Clinical Programme.